InvestLog
PHAT logo

PHAT

Phathom Pharmaceuticals, Inc.NASDAQHealthcare
$11.34+1.80%ClosedMarket Cap: $893.6M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-27Barclays—Overweight—
2026-02-27Guggenheim—Buy—
2025-10-31HC Wainwright & Co.—Buy—
2025-06-09HC Wainwright & Co.—Buy—
2025-06-09Craig-Hallum—Buy—
2025-06-06Needham—Buy—
2025-05-02Goldman Sachs—Neutral—
2025-05-02Guggenheim—Buy—
2025-05-02HC Wainwright & Co.—Buy—
2025-05-02Craig-Hallum—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$1.34$528.2M4
Sun Dec 31$3.00$745.5M6
Mon Dec 31$4.13$891.6M4
Tue Dec 31$4.93$1.02B2